Facing the Biggest Risks of the Pharma Device Supply Chain

Facing the Biggest Risks of the Pharma Device Supply Chain If 2020 was the year of reckoning for medtech supply chains, 2021 will need to be the year of resilience.  We recently delved into the vulnerabilities revealed in these supply chains, noting how a perfect storm created unprecedented pressure on firms to address resilience during and after…